Stricarb 150mg Injection
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Carboplatin (150mg)
Overview Stricarb 150mg Injection
Carbosyn 150mg Injection treats ovarian and small-cell lung cancers by inhibiting cancerous cell proliferation. Administered intravenously under medical supervision, dosage and frequency are determined individually by the physician based on the specific condition and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinuation should only occur under medical guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. Reduced blood cell counts, increasing infection and bleeding risks, are possible. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, heart, liver function, and uric acid levels are necessary. Report any allergic reaction (rash, itching, breathing difficulties) immediately. Inform your doctor of all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Primary Ingredients of Stricarb 150mg Injection
There is no text provided to rephrase. Please provide the text you wish to have rewritten.
Uses of Stricarb 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Stricarb 150mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Stricarb 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Stricarb 150mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Stricarb 150mg Injection works:
Oncaspar injection, 150mg, is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of cancerous cells, thereby inhibiting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Stricarb 150mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Stricarb 150mg Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Lactation and the use of Stricarb 150mg Injection are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Stricarb 150mg Injection might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Patients with impaired kidney function should receive Stricarb 150mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Stricarb 150mg Injection. Physician consultation is recommended. Routine monitoring of renal function is advisable during treatment.
LiverSAFE IF PRESCRIBED
The use of Stricarb 150mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Stricarb 150mg Injection :
Should you forget a Stricarb 150mg Injection, seek your physician's advice.
Facts to Know About Stricarb 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Good Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | Platinum-based anticancer agents |
3,018 People bought this recently